NOTO, LAURA
NOTO, LAURA
Emerging targeted therapies for castration-resistant prostate cancer
2012-01-01 Adamo, Vincenzo; Noto, Laura; Franchina, Tindara; Chiofalo, G; Picciotto, Maria; Toscano, G; Caristi, Nicola
New biomarkers to predict response to pemetrexed-based chemotherapy in non small cell lung cancer: from 5,10-methylenetetrahydrofolate reductase promises to miRNAs revolution.
2012-01-01 Franchina, Tindara; Bronte, G; Savio, G; Ferraro, Giuseppa; Proto, Claudia; Berenato, Rosa; Noto, Laura; Chiofalo, G; Russo, A; Adamo, Vincenzo
Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ?
2010-01-01 Franchina, Tindara; Scimone, Andrea; Ferraro, Giuseppa; Garipoli, Claudia; Zanghi', Mariangela; Berenato, Rosa; Briguglio, Roberta; Noto, Laura; Proto, Claudia; Adamo, Vincenzo
Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience.
2011-01-01 Caristi, Nicola; Franchina, Tindara; Proto, Claudia; Chiofalo, G; Toscano, G; Scimone, A; Zanghi', Mariangela; Berenato, R; Briguglio, Roberta; Denaro, Nerina; Noto, Laura; Adamo, Vincenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Emerging targeted therapies for castration-resistant prostate cancer | 1-gen-2012 | Adamo, Vincenzo; Noto, Laura; Franchina, Tindara; Chiofalo, G; Picciotto, Maria; Toscano, G; Caristi, Nicola | |
| New biomarkers to predict response to pemetrexed-based chemotherapy in non small cell lung cancer: from 5,10-methylenetetrahydrofolate reductase promises to miRNAs revolution. | 1-gen-2012 | Franchina, Tindara; Bronte, G; Savio, G; Ferraro, Giuseppa; Proto, Claudia; Berenato, Rosa; Noto, Laura; Chiofalo, G; Russo, A; Adamo, Vincenzo | |
| Predicting sensitivity of non small cell lung cancer to gefitinib and erlotinib: is there still a role for clinical factors ? | 1-gen-2010 | Franchina, Tindara; Scimone, Andrea; Ferraro, Giuseppa; Garipoli, Claudia; Zanghi', Mariangela; Berenato, Rosa; Briguglio, Roberta; Noto, Laura; Proto, Claudia; Adamo, Vincenzo | |
| Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience. | 1-gen-2011 | Caristi, Nicola; Franchina, Tindara; Proto, Claudia; Chiofalo, G; Toscano, G; Scimone, A; Zanghi', Mariangela; Berenato, R; Briguglio, Roberta; Denaro, Nerina; Noto, Laura; Adamo, Vincenzo |